drugset / Trial / NCT06122194

A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers

NCT06122194

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to estimate the oral bioavailability of 3 new formulations of PF-07817883 (test) relative to reference tablet formulation in healthy adult participants under fasted conditions. The study will also assess the safety and tolerability of test and reference tablet formulations in healthy adult participants.

Timeline

Start
2023-11-23
Primary completion
2024-01-12
Completion
2024-01-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuzatrelvir Small molecule Oral

Indications

No indication recorded.